Yohimbine prevents morphine-induced changes of glial fibrillary acidic protein in brainstem and α2-adrenoceptor gene expression in hippocampus

Neuroscience Letters

Volumn 412, Issue 2, 2007, Pages 163-167

  Alonso, Elba ^a   Garrido, Elisa ^a   Díez Fernández, Carmen ^a   Pérez García, Carmen ^a   Herradón, Gonzalo ^a,b   Ezquerra, Laura ^b   Deuel, Thomas F ^b   Alguacil, Luis F ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

2 Adrenoceptor; Glial fibrillary acidic protein; Hippocampus; Locus coeruleus; Morphine; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MORPHINE; YOHIMBINE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG ABUSE; DRUG DEPENDENCE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; NERVE CELL PLASTICITY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLITARY TRACT NUCLEUS; UPREGULATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ASTROCYTES; AUTONOMIC PATHWAYS; BIOLOGICAL MARKERS; BRAIN STEM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; LOCUS COERULEUS; MALE; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RNA, MESSENGER; SOLITARY NUCLEUS; UP-REGULATION; YOHIMBINE;

EID: 33846081782     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.11.002     Document Type: Article

References (23)

1. Alguacil L.F., and Morales L. Alpha-2 adrenoceptor ligands and opioid drugs: pharmacological interactions of therapeutic interest. Curr. Neuropharmacol. 2 (2004) 343-352
2. Bauer S., Moyse E., Jourdan F., Colpaert F., Martel J.C., and Marien M. Effects of the alpha-2 adrenoceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death. Neuroscience 117 (2003) 281-291
3. Beitner-Johnson D., Guitart X., and Nestler E.J. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61 5 (1993) 1766-1773
4. Bohem S. Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission in rat hippocampal slices. J. Physiol. 519 (1999) 439-444
5. Conway E.L., Gundlach A.L., and Craven J.A. Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 82 3 (1998) 805-817
6. Ezquerra L., Herradon G., Nguyen T., Vogt T.F., Bronson R., Silos-Santiago I., and Deuel T.F. Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta. Biochem. Biophys. Res. Commun. 323 (2004) 512-517
7. Garrido E., Pérez-García C., Alguacil L.F., and Díez-Fernández C. The alpha-2 adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration. Neurosci. Lett. 383 (2005) 141-144
8. Hameedi F.A., Woods S.W., Rosen M.I., Pearsall H.R., and Kosten T.R. Dose dependent effects of yohimbine on methadone maintained patients. Am. J. Drug Alcohol Abuse 23 (1997) 327-333
9. Herradon G., Ezquerra L., Morales L., Franklin B., Silos-Santiago I., and Alguacil L.F. Lewis and Fischer 344 strain differences in alpha-2 adrenoceptors and tyrosine hydroxylase expression. Life Sci. 78 (2006) 862-868
10. Herradon G., Ezquerra L., Nguyen T., Silos-Santiago I., and Deuel T.F. Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family. Biochem. Biophys. Res. Commun. 333 (2005) 714-721
11. Iglesias V., Alamo C., Cuenca E., Morales L., Pérez-García C., and Alguacil L.F. Effect of oral yohimbine on withdrawal jumping behaviour of morphine-dependent mice. Addict. Biol. 3 (1998) 459-463
12. Iglesias V., Alguacil L.F., Alamo C., and Cuenca E. Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur. J. Pharmacol. 211 (1992) 35-38
13. Kulkarni V.A., Jha S., and Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation of granule cells progenitors in the adult rat hippocampus. Eur. J. Neurosci. 16 (2002) 2008-2012
14. Lymperopoulos A., Karkoulias G., Koch W.J., and Flordellis C.S. Alpha-2 receptor subtype-specific activation of NF-κB in PC12 cells. Neurosci. Lett. 102 (2006) 210-215
15. Messing A., and Brenner M. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 43 (2003) 87-90
16. Morales L., Perez-Garcia C., and Alguacil L.F. Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents. Br. J. Pharmacol. 133 (2001) 172-178
17. Narita M., Suzuki M., Narita M., Yajima Y., Suzuki R., Shioda S., and Suzuki T. Neuronal protein kinase Cγ-dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine. Eur. J. Neurosci. 19 (2004) 479-484
18. Nestler E.J., Alreja M., and Aghajanian G.K. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res. Bull. 35 (1994) 521-528
19. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
20. Raghavendra V., Rutkowski M.D., and DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci. 22 (2002) 9980-9989
21. Song P., and Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci. Res. 39 (2001) 281-286
22. Taylor J.R., Lewis V.O., Elsworth J.D., Pivirotto P., Roth R.H., and Redmond D.E.J. Yohimbine co-treatment during chronic morphine administration attenuates naloxone precipitated withdrawal without diminishing tail-flick analgesia in rats. Psychopharmacology (Berlin) 103 (1991) 407-414
23. Williams J.T., Christie M.J., and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81 (2001) 299-343